Tag: intravascular lithotripsy
FastWave Medical secures multi-million dollar private financing within weeks
FastWave Medical recently announced the swift closure of an oversubscribed multi-million dollar private financing. A press release states that this achievement, secured in just...
Adding 8–12mm diameter devices to the Shockwave Peripheral Intravascular Lithotripsy toolkit
This advertorial is sponsored by Shockwave Medical.
Mazin Foteh, MD, contrasts the benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy Catheter alongside those...
AVS’ pulsatile IVL technology attracts an additional US$8.8 million to close...
AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its pulsatile intravascular lithotripsy (PIVL) therapy, has...
Shockwave Medical announces US launch of new peripheral IVL catheter
Shockwave Medical today announced the full US commercial availability of the Shockwave L6 peripheral intravascular lithotripsy (IVL) catheter following clearance by the US Food...
Shockwave IVL the “final piece of the puzzle” to safe, effective...
As the new kid on the block, endovascular treatment of the common femoral artery (CFA) just does not have that long-term outcome data yet,”...
Choose the right endograft for your patient with Shockwave IVL
Giacomo Isernia (Perugia, Italy) sits down with Vascular News to discuss the challenges posed by calcium when it comes to endograft delivery. Calcium “limits the ability...
The advantages of an endovascular approach for CFA treatment with Shockwave...
Treatment of common femoral artery (CFA) stenosis, either with an open or endovascular approach, is the subject of much debate, Raphaël Coscas (Paris, France)...
Shockwave IVL can preserve patients’ future options by increasing vessel wall...
Bella Huasen (Preston, UK) talks to Vascular News about some of the difficulties of treating occlusive disease in the femoropopliteal segment and why it is “essential...
Shockwave IVL: A paradigm shift in the treatment of common femoral...
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
Raphaël Coscas (Ambroise Paré Hospital, AP-HP...
Shockwave IVL: The last piece of the puzzle to overcome the...
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
Giacomo Isernia and Gioele Simonte...
Shockwave IVL: Improving compliance is the key to “best endovascular” CFA...
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
In this case report, Narayanan...
Shockwave IVL: Preserving options in no-stent zones
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
Bella Huasen (Lancashire Teaching Hospitals...
Shockwave IVL: Sound science reinforced by sound evidence
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
Stefano Fazzini (Tor Vergata Hospital,...
Change compliance to change the game in PAD treatment: Overcome the...
This educational supplement is sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
In this supplement:
Stefano Fazzini (Tor Vergata Hospital, Rome,...
Funding secured to advance development of Pulse IVL system
AVS has announced that it raised US$20 million in Series B financing, which the company says will accelerate clinical trial timelines for its device...
Disrupt PAD III observational study results confirm safety and effectiveness of...
The final 1,373-patient cohort analysis from the Disrupt PAD III observational study (OS) demonstrates consistent intravascular lithotripsy (IVL; Shockwave Medical) outcomes in complex and...
Shockwave IVL: Maintaining options for patients with calcified PAD
Intravascular Lithotripsy (IVL; Shockwave Medical) gives physicians “the option to treat a patient efficiently without implanting something like a stent, which would limit further...
Shockwave Medical and Genesis MedTech obtain regulatory approval in China for...
Shockwave Medical and Genesis MedTech Group announced today that they have successfully obtained approval from China’s National Medical Products Administration (NMPA) to market and...
Shockwave IVL maintains superiority to angioplasty in calcified peripheral disease at...
Shockwave Medical announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with intravascular lithotripsy (IVL) led to...
Confined by the complexity of calcium? Expand the boundaries with Shockwave...
This educational supplement is only available in selected countries and geographies.
In this supplement, sponsored by Shockwave Medical:
Marianne Brodmann (Medical University of...
Shockwave Medical announces global launch of new peripheral IVL catheter
Shockwave Medical has announced the global commercial availability of the Shockwave M5+ peripheral intravascular lithotripsy (IVL) catheter after receiving both CE mark and US...
Cardiovascular Systems announces development of IVL technology for the treatment of...
Cardiovascular Systems recently announced that it has made significant progress towards the commercialisation of intravascular lithotripsy (IVL) systems for the treatment of calcific coronary...
Shockwave Medical enrols first patient in Disrupt BTK II study for...
Shockwave Medical has announced the start of the Disrupt BTK II postmarket study to assess the safety, effectiveness and optimal clinical use of the...
CMS increases hospital outpatient payment for peripheral intravascular lithotripsy
Shockwave Medical has announced that, as part of the calendar year 2022 Medicare Hospital Outpatient Prospective Payment System (OPPS) final rule, the Centers for...
VIVA 2021: IVL “consistently” treats real-world calcium in multiple peripheral vessel...
An interim analysis from the DISRUPT PAD III observational study showed that intravascular lithotripsy (IVL; Shockwave Medical) performs “consistently well” across challenging peripheral vessels,...
CMS creates new codes that establish specific payment for IVL performed...
Shockwave Medical has announced that as part of the calendar year 2021 Medicare Hospital Outpatient Prospective Payment System (OPPS) final rule, the Centers for...
DISRUPT PAD III: Intravascular lithotripsy superior to PTA in acute procedural...
The DISRUPT PAD III randomised controlled trial (RCT) provides the largest level one evidence for the treatment of heavily calcified femoropopliteal arteries, noted William...
The emerging value and broad applicability of intravascular lithotripsy
In this supplement, sponsored by Shockwave:
Frank Arko discusses his experience with intravascular lithotripsy (IVL) and considers its value in a resource-constrained healthcare environment
...
Shockwave Medical announces that CMS has created new codes for intravascular...
Shockwave Medical announced today that the Centers for Medicare & Medicaid Services (CMS) has issued new codes for intravascular lithotripsy (IVL) procedures performed in...
Shockwave IVL can aid in eliminating recoil and dissection during below-the-knee...
George Adams (Raleigh, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–23 November, New York, USA) about the benefits of using easy-to-use Shockwave IVL (Intravascular Lithotripsy) in calcified...
IVL has “changed the dynamics” of facilitating EVAR & TEVAR in...
Frank Arko (Charlotte, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–23 November, New York, USA), about the benefits of using Shockwave Intravascular Lithotripsy (IVL) when performing EVAR...
Novel approach in treating stenotic peripheral arteries shown to be safe...
Twelve-month data prove that intravascular lithotripsy; a novel approach using pulsatile sonic pressure waves to modify intimal and medium calcium in stenotic peripheral arteries,...
“Fantastic” live case demonstrates potential value of intravascular lithotripsy
In an exciting session at the Charing Cross Symposium (CX; 24-27 April, London, UK), the audience witnessed the demonstration of a novel treatment strategy...
